» Articles » PMID: 31680623

Knockdown THOC2 Suppresses the Proliferation and Invasion of Melanoma

Overview
Journal Bioengineered
Date 2019 Nov 5
PMID 31680623
Citations 15
Authors
Affiliations
Soon will be listed here.
Abstract

Melanoma is a potentially fatal form of skin cancer with great metastatic potential. THOC2 plays a vital role in human biological progression, however, the roles of THOC2 in melanoma tumorigenesis are still unknown. In the present study, our data demonstrated that THOC2 expression was significantly increased in melanoma tissues, and high THOC2 expression was associated with poor overall survival of melanoma patients. THOC2 reduction repressed melanoma cell proliferation and invasion, and induced cell apoptosis in vitro. Microarray data revealed that the cAMP signaling pathway was significantly downregulated in A375 cells transfected with si-, which was further confirmed by RT-qPCR and bioinformatics analysis. In conclusion, our data indicated that THOC2 might act as an oncogene in melanoma progression through cAMP signaling pathway regulation, which may offer a therapeutic target for melanoma treatment.

Citing Articles

Sex differences in human pre-gastrulation embryos.

Lu Y, Qin M, Qi X, Yang M, Zhai F, Zhang J Sci China Life Sci. 2024; 68(2):397-415.

PMID: 39327393 DOI: 10.1007/s11427-024-2721-y.


Compromised transcription-mRNA export factor THOC2 causes R-loop accumulation, DNA damage and adverse neurodevelopment.

Bhattacharjee R, Jolly L, Corbett M, Wee I, Rao S, Gardner A Nat Commun. 2024; 15(1):1210.

PMID: 38331934 PMC: 10853216. DOI: 10.1038/s41467-024-45121-5.


Lnc-PKNOX1-1 inhibits tumor progression in cutaneous malignant melanoma by regulating NF-κB/IL-8 axis.

Hong A, Cao M, Li D, Wang Y, Zhang G, Fang F Carcinogenesis. 2023; 44(12):871-883.

PMID: 37843471 PMC: 10818096. DOI: 10.1093/carcin/bgad073.


THOC2 expression and its impact on 5-fluorouracil resistance in glioblastoma multiforme.

Lee Y, Jung J, Chang D, Kim M, Bashyal N, Hwang W Am J Cancer Res. 2023; 13(6):2410-2425.

PMID: 37424800 PMC: 10326588.


MiR-30e-3p inhibits gastric cancer development by negatively regulating THO complex 2 and PI3K/AKT/mTOR signaling.

Gu X, Li Y, Wang F, Ye T World J Gastrointest Oncol. 2022; 14(11):2170-2182.

PMID: 36438699 PMC: 9694264. DOI: 10.4251/wjgo.v14.i11.2170.


References
1.
Garzon R, Marcucci G, Croce C . Targeting microRNAs in cancer: rationale, strategies and challenges. Nat Rev Drug Discov. 2010; 9(10):775-89. PMC: 3904431. DOI: 10.1038/nrd3179. View

2.
Bertolotto C . Melanoma: from melanocyte to genetic alterations and clinical options. Scientifica (Cairo). 2014; 2013:635203. PMC: 3874946. DOI: 10.1155/2013/635203. View

3.
Hodi F, ODay S, Mcdermott D, Weber R, Sosman J, Haanen J . Improved survival with ipilimumab in patients with metastatic melanoma. N Engl J Med. 2010; 363(8):711-23. PMC: 3549297. DOI: 10.1056/NEJMoa1003466. View

4.
Yan Y, Yang F, Zhang H, Che J, Zheng J . Up-regulation of flotillin-2 is associated with renal cell carcinoma progression. Tumour Biol. 2014; 35(10):10479-86. DOI: 10.1007/s13277-014-2343-9. View

5.
Agaimy A, Specht K, Stoehr R, Lorey T, Markl B, Niedobitek G . Metastatic Malignant Melanoma With Complete Loss of Differentiation Markers (Undifferentiated/Dedifferentiated Melanoma): Analysis of 14 Patients Emphasizing Phenotypic Plasticity and the Value of Molecular Testing as Surrogate Diagnostic Marker. Am J Surg Pathol. 2015; 40(2):181-91. DOI: 10.1097/PAS.0000000000000527. View